Literature DB >> 12715314

Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

Francisco-Javier San-Andrés1, Rafael Rubio, Jesús Castilla, Federico Pulido, Guillermo Palao, Inmaculada de Pedro, José-Ramón Costa, Angel del Palacio.   

Abstract

Temporal trends in the incidence of opportunistic diseases (ODs) related to acquired immunodeficiency syndrome (AIDS) were studied during 1989-1997 in 1115 outpatients infected with human immunodeficiency virus (331 of whom had AIDS) in a hospital in Madrid, Spain. We analyzed the effect of adherence to antiretroviral therapy and Pneumocystis carinii pneumonia (PCP) prophylaxis on the incidence of OD. Diseases that showed a significant decreasing trend were esophageal candidiasis, pulmonary and extrapulmonary tuberculosis, and cerebral toxoplasmosis. Patients who adhered to antiretroviral therapy had a smaller risk of OD. Patients who adhered to PCP prophylaxis had a reduced risk of cerebral toxoplasmosis and PCP. A reduction in the incidence of AIDS-related ODs was observed, mainly in patients who underwent prophylaxis. Adherence to antiretroviral treatment and PCP prophylaxis was associated with a reduction in the risk of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715314     DOI: 10.1086/374358

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART).

Authors:  T R Kiderlen; O Liesenfeld; D Schürmann; T Schneider
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

2.  Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

Authors:  Joseph Lykins; Kanix Wang; Kelsey Wheeler; Fatima Clouser; Ashtyn Dixon; Kamal El Bissati; Ying Zhou; Christopher Lyttle; Andrey Rzhetsky; Rima McLeod
Journal:  Clin Infect Dis       Date:  2016-06-26       Impact factor: 9.079

3.  Toxoplasma gondii infection in hospitalized people living with HIV in Spain, 1997 to 2015.

Authors:  Marouane Menchi-Elanzi; Asunción M Mayoral; Javier Morales; Hector Pinargote-Celorio; Gregorio González-Alcaide; José-Manuel Ramos-Rincón
Journal:  Parasitol Res       Date:  2021-01-14       Impact factor: 2.289

4.  Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected children.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Hai Liu; Wanzhu Tu; Michael L Scanlon; James E Slaven; Samuel O Ayaya; Thomas S Inui
Journal:  AIDS Behav       Date:  2015-04

5.  Immune suppression of JC virus gene expression is mediated by SRSF1.

Authors:  Rahsan Sariyer; Francesca Isabella De-Simone; Jennifer Gordon; Ilker Kudret Sariyer
Journal:  J Neurovirol       Date:  2016-03-07       Impact factor: 2.643

6.  Difficulties with diagnosis and consequential poor outcome due to stigma of acquired immunodeficiency syndrome - a case report.

Authors:  Vladimira Vuletic; Branimir Nevajda; Martina Spero; Darko Chudy
Journal:  Pathog Glob Health       Date:  2013-08-01       Impact factor: 2.894

7.  Consistent ART adherence is associated with improved quality of Life, CD4 counts, and reduced hospital costs in central China.

Authors:  Honghong Wang; Jun Zhou; Gouping He; Yang Luo; Xianhong Li; Aiyun Yang; Kristopher Fennie; Ann B Williams
Journal:  AIDS Res Hum Retroviruses       Date:  2009-08       Impact factor: 2.205

8.  An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.

Authors:  Andrew J Levine; Charles H Hinkin; Kazuhiro Ando; Gianni Santangelo; Mariana Martinez; Miguel Valdes-Sueiras; Ernestina H Saxton; Glen Mathisen; Deborah L Commins; Ardis Moe; Charles Farthing; Elyse J Singer
Journal:  J Clin Exp Neuropsychol       Date:  2008-02-08       Impact factor: 2.475

9.  Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein.

Authors:  Michael Craigie; Stephanie Cicalese; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2017-11-20       Impact factor: 4.147

10.  Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Samuel O Ayaya; Eunice G Walumbe; Thomas S Inui
Journal:  Int J Behav Med       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.